Molecule to Market: Inside the outsourcing space

By molecule2market

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.

  1. 1.
    A little, big announcement...
    3:37
  2. 2.
    The CDMO start-up... with a heck of a track record
    48:09
  3. 3.
    From Big Pharma to CDMO leader
    44:05
  4. 4.
    The change optimist
    41:09
  5. 5.
    The Public Health vaccine specialist
    43:07
  6. 6.
    The academic turned biopharma innovator
    29:47
  7. 7.
    From chemist to consultant
    42:04
  8. 8.
    2021 mid-year CDMO Review: COVID-19 Vaccine Manufacturing and M&A
    32:10
  1. 9.
    The unique general
    46:19
  2. 10.
    The Stickability factor
    35:58
  3. 11.
    Poacher turned gamekeeper, turned hybrid
    50:08
  4. 12.
    The humble leader
    58:46
  5. 13.
    The understated, elite vaccine scientist
    36:25
  6. 14.
    Creating a healthy culture
    43:01
  7. 15.
    40 at 40
    44:28
  8. 16.
    From Pfizer to CDMO start-up
    35:08
  9. 17.
    Expanding drug dosage possibilities…
    45:08
  10. 18.
    From Teesside Uni to global leader
    38:38
  11. 19.
    The accidental CDMO
    36:49
  12. 20.
    The passionate problem solver
    41:43
  13. 21.
    The entrepreneurial scientist
    39:16
  14. 22.
    The sales guru
    48:47
  15. 23.
    Marathons. Wine. And 30 years in healthcare.
    52:09
  16. 24.
    The industry guru
    52:02
  17. 25.
    10 Trends for 2021
    21:23
  18. 26.
    The CDMO Disrupter
    51:51
  19. 27.
    The biologic CDMO growth guy
    49:00
  20. 28.
    Leading M&A at a top-5 global CDMO
    41:09
  21. 29.
    The virotherapy virtuoso
    48:34
  22. 30.
    Roundtable: Collaboration and driving efficiency
    1:09:01
  23. 31.
    Roundtable: Latest trends in CDMO
    1:03:44
  24. 32.
    Roundtable: Clinical trials in 2020 and beyond
    53:29
  25. 33.
    Roundtable: Global geography and the pharma and bio supply chain
    1:02:10
  26. 34.
    Scientist & champion powerlifter
    43:35
  27. 35.
    From fax to SaaS: digitising the the pharma supply chain
    46:31
  28. 36.
    Successful outsourcing partnerships: now and then
    49:42
  29. 37.
    Old world solutions won’t work for new world problems
    41:01
  30. 38.
    Looking towards the future: A continuous mindset
    38:31
  31. 39.
    Life in a boutique, specialist CDMO
    32:35
  32. 40.
    Owning your authenticity
    43:42
  33. 41.
    Building robust and scalable systems
    44:10
  34. 42.
    Entrepreneurship in the life science space
    28:51
  35. 43.
    Advocating for the CDMO sector
    43:57
  36. 44.
    The benefits of postponement packaging
    25:21
  37. 45.
    Taking the family-owned CDMO global
    33:56
  38. 46.
    The increasing demand for HPAPI
    38:15
  39. 47.
    A CDMO on the Covid-19 frontline
    35:15
  40. 48.
    Learnings from 30 years in the CDMO space
    35:47
  41. 49.
    The importance of positive, disruptive thinking
    35:43
  42. 50.
    The value of diversity In pharma
    35:48

Listen to Molecule to Market: Inside the outsourcing space now.

Listen to Molecule to Market: Inside the outsourcing space in full in the Spotify app